Assessing the value of bypassing agent therapy used prophylactic versus on-demand, during immune tolerance induction for treatment of inhibitors: a retrospective chart review

BACKGROUND: Haemophilia A is a bleeding disorder caused by deficiency of coagulation factor VIII (FVIII) which leads to severe and repeated bleedings. There is a need to understand the optimal treatment pathway for FVIII inhibitors with the use of immune tolerance induction (ITI) and the role of hae...

Descripción completa

Detalles Bibliográficos
Autores principales: Morgan, George, Back, Emily, Rosa, Doug, O’Hara, Jamie, Finnegan, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990186/
https://www.ncbi.nlm.nih.gov/pubmed/36882773
http://dx.doi.org/10.1186/s13023-023-02654-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990186/
https://www.ncbi.nlm.nih.gov/pubmed/36882773
http://dx.doi.org/10.1186/s13023-023-02654-0

Ejemplares similares